Public Profile

CSL Behring N.V.

CSL Behring N.V., a global leader in biotherapeutics, is headquartered in Belgium and operates extensively across Europe, North America, and Asia-Pacific. Founded in 1904, the company has established itself in the biotechnology industry, focusing on the development and manufacture of innovative therapies for rare and serious medical conditions. CSL Behring is renowned for its core products, including immunoglobulins, clotting factors, and albumin, which are derived from human plasma. These therapies are unique due to their high purity and efficacy, addressing critical health needs for patients with immune deficiencies and bleeding disorders. With a strong market position, CSL Behring has achieved significant milestones, including numerous regulatory approvals and a commitment to advancing patient care through research and development.

DitchCarbon Score

How does CSL Behring N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

CSL Behring N.V.'s score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.

54%

Let us know if this data was useful to you

CSL Behring N.V.'s reported carbon emissions

CSL Behring N.V., headquartered in Belgium, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company is likely to be engaged in industry-standard practices aimed at reducing carbon emissions and addressing climate change, as is common among leading firms in the biopharmaceutical sector. As the industry increasingly focuses on sustainability, CSL Behring may be expected to develop and implement strategies to enhance their environmental performance in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CSL Behring N.V.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CSL Behring N.V. is in BE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CSL Behring N.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Octapharma

CH
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Biotest

DE
Health and social work services (85)
Updated about 9 hours ago

Biogen

US
Research and development services (73)
Updated about 23 hours ago

Grifols

ES
Medical, precision and optical instruments, watches and clocks (33)
Updated about 22 hours ago

Kedrion

IT
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Swedish Orphan Biovitrum

SE
Medical, precision and optical instruments, watches and clocks (33)
Updated about 19 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers